Introduction {#Sec1}
============

Sugar acids are currently generating considerable interest because of their potential as platform chemicals and particularly their use as precursors in the manufacture of biomass derived plastics. [d]{.smallcaps}-Xylonic acid (Fig. [1](#Fig1){ref-type="fig"}), derived from the hemicellulose sugar [d]{.smallcaps}-xylose, has applications similar to [d]{.smallcaps}-gluconic acid and could serve as a [d]{.smallcaps}-gluconic acid substitute, but would be produced from non-food carbohydrate. [d]{.smallcaps}-Xylonic acid has been used in dispersal of concrete (Chun et al. [@CR12]), in the production of copolyamides (Zamora et al. [@CR46]) and as a precursor for 1,2,4-butanetriol synthesis (Niu et al. [@CR28]). Several other applications for [d]{.smallcaps}-xylonic acid have been patented.Fig. 1Formation of [d]{.smallcaps}-xylonate from [d]{.smallcaps}-xylose by NAD(P)^+^ or PQQ-dependent xylose dehydrogenases or glucose oxidase

Microbial production of [d]{.smallcaps}-xylonate was recognised already at the end of the nineteent century (Bertrand 1898, cited in Lockwood and Nelson [@CR26]) and many species of *Pseudomonas*, *Acetobacter*, *Aerobacter*, *Gluconobacter*, *Erwinia* and related genera have been shown to produce [d]{.smallcaps}-xylonate (reviewed in Buchert [@CR4]). Periplasmic [d]{.smallcaps}-xylose and [d]{.smallcaps}-glucose dehydrogenases use the pyrroloquinoline quinol (PQQ) prosthetic group to transfer electrons to cytochrome c in the respiratory chain, with a corresponding accumulation of [d]{.smallcaps}-xylonolactone or [d]{.smallcaps}-xylonate in the medium (Galar and Boiardi [@CR15]; Hardy et al. [@CR16]). [d]{.smallcaps}-Xylonolactone is the immediate product of the dehydrogenases, but the lactone generally opens spontaneously or with the aid of lactonase produced by the same species (Buchert and Viikari [@CR5]). Some bacteria and also archaea metabolise [d]{.smallcaps}-xylonic acid further via non-phosphorylative [d]{.smallcaps}-xylose metabolic pathways (Weimberg [@CR44]; Dahms [@CR13]). Cytoplasmic NAD(P)^+^-dependent [d]{.smallcaps}-xylose dehydrogenases oxidise [d]{.smallcaps}-xylose to [d]{.smallcaps}-xylonolactone (Johnsen and Schönheit [@CR19]; Johnsen et al. [@CR20]; Stephens et al. [@CR37]), which is cleaved by lactonase to [d]{.smallcaps}-xylonate in the cytoplasm. [d]{.smallcaps}-Xylonate may be dehydrated to produce 2-keto-3-deoxy pentanoate, which is further dehydrated and reduced to α-ketoglutarate or cleaved by an aldolase to pyruvate and glycolaldehyde. There are also some reports of yeast and other fungi producing [d]{.smallcaps}-xylonic acid (Suzuki and Onishi [@CR39]; Kiesling et al. [@CR23]; Kanauchi and Bamforth [@CR22]), although only one gene coding for [d]{.smallcaps}-xylose dehydrogenase has been identified in fungal species (Berghäll et al. [@CR2]). Production of [d]{.smallcaps}-xylonate from [d]{.smallcaps}-xylose by [d]{.smallcaps}-glucose oxidase has also been described (Pezzotti and Therisod [@CR31]; Chun et al. [@CR12]) and *Aspergillus niger* produces [d]{.smallcaps}-xylonate when cultivated in suitable conditions (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Production of [d]{.smallcaps}-xylonate and [d]{.smallcaps}-gluconate by *Aspergillus niger* ATCC1015 after 79 h in defined medium with 45 g [d]{.smallcaps}-xylose l^−1^ and 10 g [d]{.smallcaps}-glucose l^−1^ as carbon source. Medium was buffered with 0.1 to 2.0 % (*w*/*v*) CaCO~3~, and average pH over 79 h is shown

Recently, various yeast strains as well as the bacterium *Escherichia coli* have been engineered to produce [d]{.smallcaps}-xylonate, by the introduction of genes encoding [d]{.smallcaps}-xylose dehydrogenase (Toivari et al. [@CR41]; Nygård et al. [@CR29]; Liu et al. [@CR25]). Gene sequences for several putative [d]{.smallcaps}-xylonolactonases have recently been identified (Johnsen et al. [@CR20]; Stephens et al. [@CR37]; Brouns et al. [@CR3]), but the enzymes have not been studied. The mechanism of transport of either the linear or the lactone form of [d]{.smallcaps}-xylonate from strains with intracellular [d]{.smallcaps}-xylonate production is unknown.

In addition to the microbial production described in this review, [d]{.smallcaps}-xylonate can be produced via enzymatic (Pezzotti and Therisod [@CR31]), electrochemical (Jokic et al. [@CR21]) or chemical oxidation (Isbell and Hudson [@CR17]). [d]{.smallcaps}-Xylonic acid can also be found in acid sulphite pulping liquor of hardwood (Samuelson and Simonson [@CR34]; Pfister and Sjöström [@CR32]). However, an efficient separation method to obtain [d]{.smallcaps}-xylonate from pulping liquor has not been established.

Although a variety of applications for [d]{.smallcaps}-xylonic acid have been patented, one of which includes a method for production of crude [d]{.smallcaps}-xylonic acid from plant biomass hydrolysate (Chun et al. [@CR11]), bulk production of [d]{.smallcaps}-xylonic acid is limited. This review describes the current state in microbial production of [d]{.smallcaps}-xylonate with bacteria and fungi.

Bacterial [d]{.smallcaps}-xylonate production {#Sec2}
=============================================

Yields and conversion rates {#Sec3}
---------------------------

Of the numerous bacteria described as producers of [d]{.smallcaps}-xylonate, species of *Pseudomonas* (Lockwood and Nelson [@CR26]; Buchert et al. [@CR7]), *Gluconobacter* (Buchert [@CR4]), *Micrococcus* (Ohsugi et al. [@CR30]) and *Enterobacter* (Ishizaki et al. [@CR18]) have been the most productive (Table [1](#Tab1){ref-type="table"}). High yields of [d]{.smallcaps}-xylonate are generally associated with poor or no conversion of [d]{.smallcaps}-xylose to biomass.Table 1[d]{.smallcaps}-Xylonate production with *G. oxydans*, *Pseudomonas* species, and *Enterobacter cloacea*, *A. niger*, and engineered strains of *Escherichia coli*, *S. cerevisiae* and *K. lactis*Species[d]{.smallcaps}-Xylose (g l^−1^)[d]{.smallcaps}-Xylonate (g l^−1^)Yield~P/S~ (g g^−1^)Volumetric productivity (g l^−1^ h^−1^)Specific productivity \[g (g biomass)^−1^ h^−1^\]pHBiomass (g l^−1^)ProcessReferences*G. oxydans* (ATCC621)1001091.12.5\~1.55.51.7BatchBuchert ([@CR4])*G. oxydans* (ATCC621)1001071.12.2\~1.54.51.3BatchBuchert ([@CR4])*G. oxydans* (ATCC621)46511.11.865.50.2BatchVTT*G. oxydans* (ATCC621)40411.01.043.50.2BatchVTT*G. oxydans* (ATCC621)40371.01.52.85.50.5Continuous *D* = 0.04 h^−1^VTT*P. fragi* ATCC49731501621.11.40.26.56.9BatchBuchert and Viikari ([@CR5])*P. putida*\~0.4\~0.4\~1\~1.9\~0.76.82.9Continuous *D* = 0.2 h^−1^Hardy et al. ([@CR16])*E. cloacea*200190\~11.66.5ndBatchIshizaki et al. ([@CR18])*E. coli*40391.01.10.147.0\~8BatchLiu et al. ([@CR25])*S. cerevisiae Xyd1*2040.40.030.0075.54.6BatchToivari et al. ([@CR41])*S. cerevisiae* SUS2DD2330.40.020.0065.55.3BatchToivari et al. ([@CR42])*S. cerevisiae xylB*23170.80.230.065.55BatchToivari et al. ([@CR42])*S. cerevisiae* B67002 *xylB*49430.80.440.065.57BatchToivari et al. ([@CR42])*K. lactis Xyd1*40190.60.160.035.56BatchNygård et al. ([@CR29])*K. lactis Xyd1* Δ*XYL1*2380.40.130.015.59BatchNygård et al. ([@CR29])*A. niger* ATCC101545100.80.12\>5.5ndBatchVTTFor production potential of other bacteria, see (Buchert [@CR4]).*nd* = no data, *VTT* unpublished data from VTT, M.G. Wiebe personal communication

Although the pH optimum of the *Gluconobacter oxydans*[d]{.smallcaps}-xylose dehydrogenase is 6, [d]{.smallcaps}-xylonate has been produced at pH 4.5 (Buchert [@CR4]) and even at pH 3.5 (Fig. [3](#Fig3){ref-type="fig"}, Table [1](#Tab1){ref-type="table"}). Production rates are approximately 2 g [d]{.smallcaps}-xylonate l^−1^ h^−1^ at pH 4.5--6.5, even when biomass concentration is low (0.2 g biomass l^−1^) and no cell growth occurs (Table [1](#Tab1){ref-type="table"}, Buchert [@CR4]). We have observed specific production rates up to 12 g [d]{.smallcaps}-xylonate (g biomass)^−1^ h^−1^ at pH 5.6.Fig. 3[d]{.smallcaps}-Xylonate production by *Gluconobacter oxydans* ATCC621 from [d]{.smallcaps}-xylose in YE supplemented defined medium with 45 g [d]{.smallcaps}-xylose l^−1^ at pH 5.6 (*filled circle*) or pH 3.5 (*empty circle*) and from acid hydrolysed DDGS at pH 5.6 (*filled square*) or pH 3.5 (*empty square*). *Error bars* represent ±SEM for duplicate cultures

Since *G. oxydans* requires complex growth medium and efficiently converts most sugars to acids rather than biomass, other species may be more cost effective for [d]{.smallcaps}-xylonate production. *Pseudomonas fragi* ATCC4973 produces [d]{.smallcaps}-xylonate at similar volumetric rates to *G. oxydans*, but at lower specific rate (Table [1](#Tab1){ref-type="table"}, Buchert and Viikari [@CR5]), and production is more sensitive to pH and hydrolysate inhibitors (Buchert et al. [@CR7], [@CR8]). Various other bacteria also produce [d]{.smallcaps}-xylonate and some such as *Gluconoacetobacter diazotrophicus*, which has been considered as an alternative to *Gluconobacter* for [d]{.smallcaps}-gluconate production because of its minimal nutritional requirements and low pH tolerance (Attwood et al. [@CR1]) could also be considered for [d]{.smallcaps}-xylonate production.

The first example of bacteria engineered for [d]{.smallcaps}-xylonate production was recently described by Liu et al. ([@CR25]). By introducing a [d]{.smallcaps}-xylose dehydrogenase encoding gene, *xylB* from *Caulobacter crescentus*, into *E. coli* strain W3110 and by blocking the endogenous pathways for [d]{.smallcaps}-xylose and [d]{.smallcaps}-xylonate metabolism, they were able to produce 39 g l^−1^[d]{.smallcaps}-xylonic acid from 40 g l^−1^[d]{.smallcaps}-xylose in a batch process (Table [1](#Tab1){ref-type="table"}).

Although continuous production of [d]{.smallcaps}-xylonate has not been reported, continuous production of [d]{.smallcaps}-gluconic (e.g. Attwood et al. [@CR1]), 2-keto-[l]{.smallcaps}-gulonic (e.g. Takagi et al. [@CR40]) and 2,5-diketogluconic (e.g. Buse et al. [@CR9], [@CR10]) acids have been described. Hardy et al. ([@CR16]) described the production of [d]{.smallcaps}-xylonate at a rate of \~4 mmol (g biomass)^−1^ h^−1^ as a by-product for enhanced biomass yield of *Pseudomonas putida* on [d]{.smallcaps}-glucose or lactate at *D* = 0.2 h^−1^, pH 6.8 (Table [1](#Tab1){ref-type="table"}). With *G. oxydans*, we have observed continuous production of [d]{.smallcaps}-xylonate with *G. oxydans* at a rate of 1.5 g [d]{.smallcaps}-xylonate l^−1^ h^−1^ at *D* = 0.04 h^−1^ with 40 g [d]{.smallcaps}-xylose l^−1^ and 20 g [d]{.smallcaps}-glucose l^−1^ at pH 5.5 (Fig. [4](#Fig4){ref-type="fig"}, Table [1](#Tab1){ref-type="table"}). In addition, [d]{.smallcaps}-gluconate, acetate and biomass were produced. Continuous production at pH 4.5 was also possible (Fig. [4](#Fig4){ref-type="fig"}). Conditions for [d]{.smallcaps}-xylonate production in fed-batch cultures have not been reported.Fig. 4[d]{.smallcaps}-Gluconate, [d]{.smallcaps}-xylonate, acetate and biomass production, volumetric [d]{.smallcaps}-xylonate production rate and specific [d]{.smallcaps}-xylonate production rate by *Gluconobacter oxydans* ATCC621 in chemostat culture with YE supplemented defined medium containing 10 g [d]{.smallcaps}-glucose l^−1^ and 40 g [d]{.smallcaps}-xylose l^−1^ at *D* = 0.04 h^−1^, pH 5.5 or 4.5. *Error bars* represent ±SEM for triplicate (pH 5.5) or duplicate (pH 4.5) samples

Hydrolysate {#Sec4}
-----------

Lignocellulosic waste biomass would provide an economic raw material for [d]{.smallcaps}-xylonate production, and several studies have been carried out on the conversion of [d]{.smallcaps}-xylose to [d]{.smallcaps}-xylonate in hemicellulose hydrolysates (Chun et al. [@CR12]; Buchert et al. [@CR8]). These are summarised in Table [2](#Tab2){ref-type="table"}. *G. oxydans* was found to be more tolerant to toxins in biomass hydrolysate than *P. fragi*, but growth and [d]{.smallcaps}-xylonate production were still inhibited by high concentrations of lignocellulosic hydrolysate. Pre-treatment by diethylether extraction, adsorption on mixed bed resin or ion exclusion chromatography enabled conversion of [d]{.smallcaps}-xylose in hydrolysate to [d]{.smallcaps}-xylonate by *G. oxydans*, with the biggest improvements seen when treated by ion exclusion chromatography (Table [2](#Tab2){ref-type="table"}).Table 2Production of [d]{.smallcaps}-xylonate from lignocellulosic hydrolysates with *G. oxydans* ATCC621[d]{.smallcaps}-Xylose (g l^−1^)[d]{.smallcaps}-Xylonate (g l^−1^)Volumetric productivity (g [d]{.smallcaps}-xylonate l^−1^ h^−1^)HydrolysateReferences25\~130.2Birchwood, steamBuchert et al. ([@CR8])25\~220.3Birchwood, steam, ether extractedBuchert et al. ([@CR8])100\~881.2Birchwood, steam, ion exclusionBuchert et al. ([@CR6])\~45\~48\~0.5Birch spent sulphite liquorChun et al. ([@CR12])39170.4Wheat straw (ABNT), C5 fraction derived^a^ from steam pre-treatmentTurkia et al. ([@CR43])na541.1Wheat straw (ABNT), C5 fraction derived^a^ from steam pre-treatment, overlimedVTT35350.6DDGS (ABNT), acid hydrolysedVTT25130.3DDGS (ABNT), acid hydrolysed, continuous at *D* = 0.03 h^−1^VTT2350.1DDGS (ABNT), acid hydrolysed, overlimed, continuous at *D* = 0.02 h^−1^VTTWhen described, cultures were maintained at pH 5.5--6.5*ABNT* Abengoa Bioenergia Nuevas Tecnologias, *VTT* unpublished data from VTT, M.G. Wiebe personal communication, *na* not available^a^Provided by Dr. Robert Bakker, Wageningen University & Research Centre

Turkia et al. ([@CR43]) also observed a low rate for the conversion of [d]{.smallcaps}-xylose to [d]{.smallcaps}-xylonate by *G. oxydans* ATCC621 (E97003) in a pentose-rich hydrolysate derived from wheat straw, with incomplete conversion of the [d]{.smallcaps}-xylose and a low yield of \~0.7 g [d]{.smallcaps}-xylonate (g [d]{.smallcaps}-xylose consumed)^−1^. Overliming (Mohagheghi et al. [@CR27]) the hydrolysate to remove some of the aromatic and aliphatic compounds was sufficient to enable full conversion of the hydrolysate \[yield 1.0 g [d]{.smallcaps}-xylonate (g [d]{.smallcaps}-xylose consumed)^−1^\] and to improve the production rate to 1.1 g [d]{.smallcaps}-xylonate l^−1^ h^−1^ with an inoculum of only 1.0--1.5 g biomass l^−1^ (Fig. [5](#Fig5){ref-type="fig"}). The rate was thus only slightly lower than that observed with pure [d]{.smallcaps}-xylose and similar to that obtained by hydrolysate treated with ion exclusion chromatography. In contrast, overliming acid hydrolysed dried distillers grain solids (DDGS) from Abengoa Bioenergia Nuevas Tecnologias (ABNT, Spain) resulted in poorer conversion of the [d]{.smallcaps}-xylose to [d]{.smallcaps}-xylonate than in the untreated hydrolysate (Table [2](#Tab2){ref-type="table"}).Fig. 5[d]{.smallcaps}-Xylonate produced (solid symbols) and [d]{.smallcaps}-xylose consumed (*open symbols*) by *Gluconobacter oxydans* ATCC621 in pre-treated wheat straw derived hydrolysate (C5 fraction), with (*circles*) or without (*squares*) overliming, and supplemented with 5 g yeast extract l^−1^ at pH 5.6, 30 °C. The hydrolysate contained [d]{.smallcaps}-xylose, [d]{.smallcaps}-glucose, L-arabinose, and acetate. [d]{.smallcaps}-Xylonate measurements in untreated wheat straw hydrolysate are shown in Turkia et al. ([@CR43])

Chun et al. ([@CR12]) found that *G. oxydans* was able to completely convert [d]{.smallcaps}-xylose in diluted spent sulphite liquor even though no cell growth occurred. Conversion rates with high cell density (\~4.6 g biomass l^−1^) were comparable to those in ether-extracted birchwood hydrolysate and untreated wheat straw hydrolysate (Table [2](#Tab2){ref-type="table"}, Chun et al. [@CR12]).

In continuous flow culture at *D* = 0.03 h^−1^, [d]{.smallcaps}-xylonate was produced by *G. oxydans* at a rate of 0.32 g [d]{.smallcaps}-xylonate l^−1^ h^−1^ for up to 3 days (Table [1](#Tab1){ref-type="table"}). However, only \~50 % of the [d]{.smallcaps}-xylose in the hydrolysate was converted to [d]{.smallcaps}-xylonate, and the cells were being washed out. Approximately 76 % [d]{.smallcaps}-glucose in the hydrolysate was converted to [d]{.smallcaps}-gluconate.

Recombinant yeast for [d]{.smallcaps}-xylonate production {#Sec5}
=========================================================

*S. cerevisiae* and the choice of [d]{.smallcaps}-xylose dehydrogenase {#Sec6}
----------------------------------------------------------------------

Toivari et al. ([@CR41]) described the production of [d]{.smallcaps}-xylonate by *S. cerevisiae* expressing an NADP^+^-dependent xylose dehydrogenase from *T. reesei*. The engineered *S. cerevisiae* strains produced up to 3.8 g [d]{.smallcaps}-xylonate l^−1^ (Table [1](#Tab1){ref-type="table"}). Xylitol (4.8 g l^−1^) was the primary by-product and could be significantly reduced by deleting the aldose reductase encoded by *GRE3* (Toivari et al. [@CR41]). Although this demonstrated the feasibility of producing [d]{.smallcaps}-xylonate with yeast, the titres and rates were low compared to those obtained with bacteria (see above) or for other acids produced in *S. cerevisiae*, e.g. lactate \>100 g l^−1^ (Sauer et al. [@CR35]).

Initial attempts at redox engineering to improve NADP^+^-recycling did not improve [d]{.smallcaps}-xylonate production (Toivari et al. [@CR41]), and the activity of alternative [d]{.smallcaps}-xylose dehydrogenases was assessed in *S. cerevisiae* (Toivari et al. [@CR42], Table [1](#Tab1){ref-type="table"}). The *C. crescentus xylB* encoded NAD^+^-dependent [d]{.smallcaps}-xylose dehydrogenase was found to have high activity in *S. cerevisiae*, and strains expressing *xylB* produced more [d]{.smallcaps}-xylonate (17 ± 2 g l^−1^) at a higher rate than the X*yd1* expressing strain (Table [1](#Tab1){ref-type="table"}, Toivari et al. [@CR42]). In addition to high activity, the xylB had high specificity for [d]{.smallcaps}-xylose (Toivari et al. [@CR42]). This increase in [d]{.smallcaps}-xylonate production with *xylB* compared to *Xyd1* presumably reflects the higher activity of the dehydrogenase in the cytoplasm. However, it may also indicate that production of excess NADH, which can be oxidised in the electron transport chain to generate energy, is preferable to production of excess NADPH. Another NADP^+^ requiring [d]{.smallcaps}-xylose dehydrogenase, SUS2DD from pig liver, which was successfully expressed in *S. cerevisiae*, showed similar activity and production characteristics to the *T. reesei Xyd1* (Table [1](#Tab1){ref-type="table"}, Toivari et al. [@CR42]).

Expression of *xylB* in the industrial *S. cerevisiae* strain B67002 enabled the production of higher concentrations of [d]{.smallcaps}-xylonate (e.g. 43 g l^−1^) than with the lab strain, at rates approaching 0.5 g l^−1^ h^−1^, i.e. 25--30 % those observed with *Gluconobacter* and *Pseudomonas* spp. (Table [1](#Tab1){ref-type="table"}; Toivari et al. [@CR42]).

Only limited research has been carried out on the environmental conditions that are required for good [d]{.smallcaps}-xylonate production by *S. cerevisiae*. Production has primarily been characterised at pH 5.5. [d]{.smallcaps}-Xylonate could also be produced at pH 3, but production and cell viability were reduced compared to that observed at pH 5.5 (Toivari et al. [@CR42]). Similarly, low productivity at low pH has also been observed with lactic acid production (Porro et al. [@CR33]). [d]{.smallcaps}-Xylonate accumulated intracellularly (Toivari et al. [@CR42]), revealing a potential need to engineer [d]{.smallcaps}-xylonate transport. [d]{.smallcaps}-Xylonate production has been shown to be an energy requiring process, with production essentially stopping once metabolisable carbon has been consumed, but resuming when additional co-substrate is added (Toivari et al. [@CR41]). Since most biomass hydrolysates, even C5-enriched fractions, contain some C6 sugars, co-substrate would be at least partly provided from the biomass hydrolysate. Because [d]{.smallcaps}-xylonate production produces NADH (or NADPH), which needs to be oxidized, ultimately by channelling electrons to oxygen, the process must be aerobic. However, the energy produced in the reduction of oxygen will provide energy for the process, including [d]{.smallcaps}-xylonate transport (if active), pH homeostasis and cell maintenance.

When a putative [d]{.smallcaps}-xylono-lactone lactonase *xylC* from *C. crescentus* was expressed together with *xylB* in *S. cerevisiae*, increased lactonase activity was observed by NMR. More extracellular [d]{.smallcaps}-xylonate was initially produced than with cells lacking *xylC* at both pH 5.5 and 3 (Toivari et al. [@CR42]). The lactonase-expressing strain also sustained higher production at pH 3. However, expression of the lactonase encoding gene decreased cell vitality and viability when [d]{.smallcaps}-xylonate was produced at pH 3.0 (Toivari et al. [@CR42]).

Alternative yeast for [d]{.smallcaps}-xylonate production {#Sec7}
---------------------------------------------------------

[d]{.smallcaps}-Xylonate production has also been demonstrated with the [d]{.smallcaps}-xylose-utilising yeast *K. lactis*. [d]{.smallcaps}-Xylonate was produced in *K. lactis* with the Xyd1 enzyme from *T. reesei*, which is NADP^+^-dependent and has relatively low activity. Although the activity levels were similar to those observed in *S. cerevisiae*, *K. lactis* produced more [d]{.smallcaps}-xylonate (6.3 ± 0.1 g l^−1^) at a higher rate (Nygård et al. [@CR29]), compared to *S. cerevisiae* expressing the same gene. Increasing the substrate concentration led to higher productivity (19 ± 2 g l^−1^ at rates of 0.16 ± 0.01 g l^−1^ h^−1^, Table [1](#Tab1){ref-type="table"}; Nygård et al. [@CR29]), whereas the equivalent *S. cerevisiae* strains did not increase [d]{.smallcaps}-xylonate production when provided higher [d]{.smallcaps}-xylose concentrations. The natural ability to utilize [d]{.smallcaps}-xylose not only may benefit [d]{.smallcaps}-xylonate production by decreasing the need for added co-substrate but also decreases the overall yield and thus should be optimized to support good productivity without substantial loss in yield.

In *K. lactis* the deletion of the xylose reductase (encoded by *XYL1*) resulted not only in less xylitol production compared to the reductase containing strain but also increased [d]{.smallcaps}-xylonate production (Nygård et al. [@CR29]), in contrast to the effect of deleting *GRE3* from *S. cerevisiae*, which only reduced xylitol production (Toivari et al. [@CR41]). With *K. lactis*, oxygen provision affected the conversion of [d]{.smallcaps}-xylose to [d]{.smallcaps}-xylonate, xylitol or biomass. Metabolism of [d]{.smallcaps}-xylose was most efficient with high oxygen provision (12 mmol O~2~ l^−1^ h^−1^), but even with low oxygen concentration (6 mmol O~2~ l^−1^ h^−1^), no loss in [d]{.smallcaps}-xylonate titre or production rate occurred.

*K. lactis* is not particularly tolerant to biomass hydrolysates, but its good [d]{.smallcaps}-xylonate production ability demonstrates the potential benefit of producing [d]{.smallcaps}-xylonate in a [d]{.smallcaps}-xylose-utilising non-*Saccharomyces* yeast.

The prospects for future microbial [d]{.smallcaps}-xylonate production {#Sec8}
======================================================================

Although the non-engineered bacteria are very efficient at producing [d]{.smallcaps}-xylonate, neither commercial production has been described, nor have cost effective, large-scale separation processes been developed. The current methods, e.g., precipitation or ion exchange, are for small-scale preparations from relatively pure solutions (Liu et al. [@CR25]; Buchert et al. [@CR7]; Devos and Huchette [@CR14]) and would not be adequate for bulk production of [d]{.smallcaps}-xylonic acid required for use as a platform chemical, e.g., for polymer or hydrogel production. Since there is no historic market for [d]{.smallcaps}-xylonate, there has been no driving force to develop large-scale production. However, with the increasing need to replace petrochemicals and compounds derived from [d]{.smallcaps}-glucose, such as [d]{.smallcaps}-gluconate, with alternative chemicals, interest in large-scale production and purification of [d]{.smallcaps}-xylonate will grow.

Production of [d]{.smallcaps}-xylonate by *G. oxydans* has been limited by complex nutritional requirements and low biomass production, requiring costly inoculum development, even if [d]{.smallcaps}-xylonate could then be produced from biomass hydrolysates. Several patents improving biomass production by *G. oxydans* have been published (Zhao et al. [@CR47]; Yuan et al. [@CR45]; Shingoh [@CR36]), but strategies that disrupt the peri- or cytoplasmic glucose dehydrogenases (Shingoh [@CR36]) are expected to also reduce the [d]{.smallcaps}-xylonate production rate. *P. fragi* would provide more robust inoculum development, but would require more extensive treatment to remove inhibitors from the biomass hydrolysates than *G. oxydans* (Buchert et al. [@CR8]). *G. diazotrophicus* may be a reasonable alternative (Attwood et al. [@CR1]), but has not been evaluated in hydrolysate. Another major concern with these bacteria is the range of acidic products produced from the compounds present in lignocellulosic hydrolysates and their separation costs.

Genetically engineered bacteria and yeast now provide new alternatives to the non-engineered bacteria for large-scale production of [d]{.smallcaps}-xylonate and are likely to be developed further. The engineered *E. coli* strain provides benefits in having a fast specific growth rate, efficient generation of inoculum, and low nutrient requirements. Yeast such as *S. cerevisiae* and *K. lactis* also have good growth and low nutritional requirements. *S. cerevisiae* and several other yeast (e.g. Kwon et al. [@CR24]) additionally offer good tolerance to the various inhibitors found in lignocellulosic hydrolysates, as well as tolerance to low pH conditions and even the capacity for acid production at low pH (cf. lactic acid production at pH 3, Suominen et al. [@CR38]). The development of genetically engineered production strains opens new doors for the development of robust industrial processes for [d]{.smallcaps}-xylonic acid production.
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